Literature DB >> 8904454

Emergence of fluconazole-resistant strains of Blastoschizomyces capitatus causing nosocomial infections in cancer patients.

D D'Antonio1, A Mazzoni, A Iacone, B Violante, M A Capuani, F Schioppa, F Romano.   

Abstract

Blastoschizomyces capitatus strains resistant to fluconazole were isolated in three cancer patients. All of the strains had identical genomic DNA restriction profiles. Our findings give evidence for the emergence of fluconazole-resistant B. capitatus and suggest a nosocomial acquisition emanating from a common source within the hospital environment.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8904454      PMCID： PMC228886          DOI： 10.1128/jcm.34.3.753-755.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  14 in total

1.  [Trichosporon capitatum septicemia in immunosuppressed patients].

Authors:  R Herbrecht; K L Liu; H Koenig; J Waller; P Dufour; F Maloisel; J P Bergerat; F Oberling
Journal:  Pathol Biol (Paris)       Date:  1990-06

2.  Application of DNA typing methods to epidemiology and taxonomy of Candida species.

Authors:  S Scherer; D A Stevens
Journal:  J Clin Microbiol       Date:  1987-04       Impact factor: 5.948

3.  Risk factors for candidemia in cancer patients: a case-control study.

Authors:  A Karabinis; C Hill; B Leclercq; C Tancrède; D Baume; A Andremont
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

4.  Immunoblot analysis of the serological response in invasive Trichosporon beigelii and Blastoschizomyces capitatus infections.

Authors:  R C Matthews; J P Burnie; A Fox; M Woods; S Tabaqchali
Journal:  J Clin Microbiol       Date:  1986-02       Impact factor: 5.948

5.  Fluconazole resistance in Candida glabrata.

Authors:  D W Warnock; J Burke; N J Cope; E M Johnson; N A von Fraunhofer; E W Williams
Journal:  Lancet       Date:  1988-12-03       Impact factor: 79.321

6.  Modification of potassium nitrate assimilation test for identification of clinically important yeasts.

Authors:  D H Pincus; I F Salkin; N J Hurd; I L Levy; M A Kemna
Journal:  J Clin Microbiol       Date:  1988-02       Impact factor: 5.948

7.  In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole.

Authors:  G Morace; S Manzara; G Dettori
Journal:  Chemotherapy       Date:  1991       Impact factor: 2.544

Review 8.  Disseminated Trichosporon capitatum infection in a patient with acute leukemia undergoing bone marrow transplantation.

Authors:  K L Liu; R Herbrecht; J P Bergerat; H Koenig; J Waller; F Oberling
Journal:  Bone Marrow Transplant       Date:  1990-09       Impact factor: 5.483

9.  Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection.

Authors:  M Ruhnke; A Eigler; I Tennagen; B Geiseler; E Engelmann; M Trautmann
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

10.  Fluconazole treatment of Blastoschizomyces capitatus meningitis in an allogeneic bone marrow recipient.

Authors:  C Girmenia; A Micozzi; M Venditti; G Meloni; A P Iori; S Bastianello; P Martino
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-09       Impact factor: 3.267
View more
  13 in total

Review 1.  Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.

Authors:  M A Pfaller; D J Diekema
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

Review 2.  Candida albicans Biofilms and Human Disease.

Authors:  Clarissa J Nobile; Alexander D Johnson
Journal:  Annu Rev Microbiol       Date:  2015       Impact factor: 15.500

Review 3.  Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature.

Authors:  Corrado Girmenia; Livio Pagano; Bruno Martino; Domenico D'Antonio; Rosa Fanci; Giorgina Specchia; Lorella Melillo; Massimo Buelli; Giampaolo Pizzarelli; Mario Venditti; Pietro Martino
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

4.  Efficacy of Posaconazole in a Murine Model of Systemic Infection by Saprochaete capitata.

Authors:  Pamela Thomson; Josep Guarro; Emilio Mayayo; Javier Capilla
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

Review 5.  Geotrichum capitatum septicemia: case report and review of the literature.

Authors:  H Trabelsi; S Néji; L Gargouri; H Sellami; R Guidara; F Cheikhrouhou; H Bellaaj; F Makni; M Elloumi; A Ayadi
Journal:  Mycopathologia       Date:  2015-02-14       Impact factor: 2.574

6.  Onychomycosis caused by Blastoschizomyces capitatus.

Authors:  D D'Antonio; F Romano; A Iacone; B Violante; P Fazii; E Pontieri; T Staniscia; C Caracciolo; S Bianchini; R Sferra; A Vetuschi; E Gaudio; G Carruba
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

7.  Genotyping and antifungal susceptibility profile of Dipodascus capitatus isolates causing disseminated infection in seven hematological patients of a tertiary hospital.

Authors:  Ignacio Gadea; Manuel Cuenca-Estrella; Elena Prieto; Teresa M Diaz-Guerra; Jose I Garcia-Cia; Emilia Mellado; Jose F Tomas; Juan L Rodriguez-Tudela
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

8.  In vitro susceptibility testing of Geotrichum capitatum: comparison of the E-test, disk diffusion, and Sensititre colorimetric methods with the NCCLS M27-A2 broth microdilution reference method.

Authors:  C Girmenia; G Pizzarelli; D D'Antonio; F Cristini; P Martino
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

Review 9.  Spondylodiscitis due to an emergent fungal pathogen: Blastoschizomyces capitatus, a case report and review of the literature.

Authors:  Aygul Dogan Celik; Resat Ozaras; Serda Kantarcioglu; Ali Mert; Fehmi Tabak; Recep Ozturk
Journal:  Rheumatol Int       Date:  2009-04-16       Impact factor: 2.631

10.  Case of fatal Blastoschizomyces capitatus infection occurring in a patient receiving empiric micafungin therapy.

Authors:  Paul Chittick; Elizabeth L Palavecino; Brian Delashmitt; James Evans; James E Peacock
Journal:  Antimicrob Agents Chemother       Date:  2009-09-08       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.